Access to new direct-acting antiviral agents against HCV infection: A view from Spain.
作者信息
Tomé Santiago, Otero Esteban
机构信息
Hepatology Unit, Internal Medicine Department Hospital Universitario de Santiago Santiago de Compostela Spain.
出版信息
Clin Liver Dis (Hoboken). 2015 Mar 4;5(1):22-23. doi: 10.1002/cld.444. eCollection 2015 Jan.
Abstract
摘要
相似文献
1
Access to new direct-acting antiviral agents against HCV infection: A view from Spain.获得针对丙型肝炎病毒感染的新型直接抗病毒药物：西班牙的视角。
Clin Liver Dis (Hoboken). 2015 Mar 4;5(1):22-23. doi: 10.1002/cld.444. eCollection 2015 Jan.
2
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.一项前瞻性队列研究表明，在现实生活中，与单纯丙型肝炎病毒（HCV）感染个体相比，合并感染人类免疫缺陷病毒（HIV）的患者对基于直接作用抗病毒药物的慢性丙型肝炎治疗反应更差。
HIV Clin Trials. 2017 May;18(3):126-134. doi: 10.1080/15284336.2017.1330801.
3
Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents.在直接作用抗病毒药物时代，基于他汀类药物（3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂）治疗丙型肝炎病毒（HCV）感染相关疾病
F1000Res. 2016 Feb 26;5:223. doi: 10.12688/f1000research.7970.3. eCollection 2016.
4
Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.直接作用抗病毒药物治疗丙型肝炎病毒在合并或未合并HIV感染患者中的疗效相似。
AIDS. 2017 Jun 1;31(9):1253-1260. doi: 10.1097/QAD.0000000000001465.
5
Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.直接作用抗病毒疗法治疗肾移植受者丙型肝炎病毒感染。
Kidney Int. 2018 Mar;93(3):560-567. doi: 10.1016/j.kint.2017.10.024. Epub 2018 Jan 9.
6
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.直接作用抗病毒药物治疗丙型肝炎患者的疱疹病毒再激活。
Clin Gastroenterol Hepatol. 2016 Nov;14(11):1662-1666.e1. doi: 10.1016/j.cgh.2016.05.016. Epub 2016 May 20.
7
Male Sexual Dysfunction Among Egyptian Patients with Chronic Hepatitis C Virus Infection Before and After Direct-Acting Antiviral Drugs.埃及慢性丙型肝炎病毒感染患者直接抗病毒药物治疗前后的男性性功能障碍。
J Sex Med. 2019 Mar;16(3):402-409. doi: 10.1016/j.jsxm.2019.01.309.
8
Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.直接抗病毒药物时代肝移植候选者中丙型肝炎病毒治疗的时机
J Clin Transl Hepatol. 2017 Dec 28;5(4):363-367. doi: 10.14218/JCTH.2017.00007. Epub 2017 Sep 14.
9
[Direct-acting antiviral agents, hepatitis C and dialysis: an update].[直接作用抗病毒药物、丙型肝炎与透析：最新进展]
G Ital Nefrol. 2018 Sep;35(5).
10
Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.短文：直接抗病毒药物治疗期间丙型肝炎病毒慢性感染患者的病毒动力学：对监测和优化治疗疗程的影响
Eur J Gastroenterol Hepatol. 2017 Jul;29(7):781-785. doi: 10.1097/MEG.0000000000000882.
引用本文的文献
1
Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coated tablets and profiling degradants.RP-UHPLC-DAD-MS用于薄膜包衣片中索磷布韦定性和定量分析及降解产物剖析的潜力
J Pharm Anal. 2017 Aug;7(4):208-213. doi: 10.1016/j.jpha.2017.04.003. Epub 2017 Apr 14.
本文引用的文献
1
Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C.索磷布韦治疗丙型肝炎患者的成本效益
J Viral Hepat. 2015 Apr;22(4):376-83. doi: 10.1111/jvh.12311. Epub 2014 Sep 15.
2
Treating hepatitis C in lower-income countries.在低收入国家治疗丙型肝炎。
N Engl J Med. 2014 May 15;370(20):1869-71. doi: 10.1056/NEJMp1400160. Epub 2014 Apr 10.
3
Hepatitis C in the United States.美国的丙型肝炎
N Engl J Med. 2013 May 16;368(20):1859-61. doi: 10.1056/NEJMp1302973.
4
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care.全球丙型肝炎概况：医生的知识、意见和对护理的认知障碍。
Hepatology. 2013 Apr;57(4):1325-32. doi: 10.1002/hep.26246.
5
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.全球丙型肝炎病毒感染的流行病学：特定年龄组丙型肝炎病毒抗体血清流行率的新估计。
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.
6
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.1999 年至 2007 年期间，美国因病毒性肝炎导致的死亡率负担不断增加。
Ann Intern Med. 2012 Feb 21;156(4):271-8. doi: 10.7326/0003-4819-156-4-201202210-00004.
7
Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score.肝移植中质量调整生命年的成本：适应证和终末期肝病模型评分的影响。
Liver Transpl. 2011 Nov;17(11):1333-43. doi: 10.1002/lt.22388.
Zotero 插件